These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Grompe M, Lindstedt S, al-Dhalimy M, Kennaway NG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M. Nat Genet; 1995 Aug; 10(4):453-60. PubMed ID: 7545495 [Abstract] [Full Text] [Related]
28. Type 1 Tyrosinaemia. Mannion MA, Smith A, Mayne P, Monavari AA. Ir Med J; 2016 Jun 10; 109(6):426. PubMed ID: 27814443 [Abstract] [Full Text] [Related]
37. Neonatal screening for hereditary tyrosinaemia: are we there yet? Hadžić N, Vara R. Arch Dis Child; 2015 Aug 10; 100(8):720-1. PubMed ID: 25957320 [No Abstract] [Full Text] [Related]
38. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1. Li L, Zhang Q, Yang H, Zou Q, Lai C, Jiang F, Zhao P, Luo Z, Yang J, Chen Q, Wang Y, Newsome PN, Frampton J, Maxwell PH, Li W, Chen S, Wang D, Siu TS, Tam S, Tse HF, Qin B, Bao X, Esteban MA, Lai L. J Biol Chem; 2017 Mar 17; 292(11):4755-4763. PubMed ID: 28053091 [Abstract] [Full Text] [Related]